Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home Library Health Topics Collection Guidelines Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology. NGC:006656
Document Actions

Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. American Academy of Neurology. NGC:006656

Publication Details
Author(s):
  • AHRQ (US) - Agency for Healthcare Research and Quality
Country(ies) of application:
  • United States
Language(s):
  • English
Type of Publication:
Guideline Clearing Report
Publication URL:
Open Publication URL in a new window
Publication Scope:
  • Assessment/diagnosis
  • Management
Publication Status:
Published
Date of publication:
May 06, 2008
Due for Review:
-
Diseases / Conditions Addressed
MeSH Terms addressed:
  • Musculoskeletal Diseases (C05)
    • Muscular Diseases (C05.651)
  • Neurological Disorders / Nervous System Diseases (C10)
    • Central Nervous System Diseases (C10.228)
    • Neurologic Manifestations (C10.597)
  • Signs and Symptoms (C23.888)
    • Neurologic Manifestations (C23.888.592)
  • Pharmacologic Actions (D27.505)
  • Pediatrics (G02.403.776.610)
Guideline key questions
Page last updated: Jan 14, 2010

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.